Our investigations showed that DYRK1B levels are increased in the liver of patients with nonalcoholic steatohepatitis (NASH) and in mice fed with a high-fat, high-sucrose diet. Here, DYRK1B is linked to metabolic dysfunction-associated steatohepatitis.